TDMA
|
Material
|
|
Sample A/B: Lyophilized serum, each 3,0 mL Sample C/D: Lyophilized serum, each 3,0 mL
|
|
Analytes
|
|
sample A/B
|
sample
C/D
|
|
|
-
clozapine
- N-desmethylclozapine
- olanzapine
- quetiapine
- amisulpride
|
-
risperidone
- 9-hydroxyrisperidone
- ziprasidone
- citalopram
- perazine
|
|
|
concentration ranges, µg/L
|
|
-
clozapine
|
100
- 1500
|
-
risperidone
|
1 - 15
|
|
-
N-desmethylclozapine
|
100
- 1500
|
-
9-hydroxyrisperidone
|
5 - 150
|
|
-
olanzapine
|
10
- 100
|
-
perazine
|
25 - 600
|
|
-
quetiapine
|
25
- 600
|
-
ziprasidone
|
10 - 150
|
|
-
amisulpride
|
50 - 500
|
-
citalopram
|
10 - 300
|
|
|
|
|
|
|
|
|
Examinations requested
|
|
Quantitative determination of the analytes
|
|
Distributions
|
|
TDMA
1/12
|
TDMA
2/12
|
TDMA
3/12
|
|
|
28-Feb - 26-Mar
|
12-Jun - 09-Jul
|
09-Oct - 05-Nov
|
|
|
Fees
|
|
|
|
|
|
order no.
|
description
|
members
|
non members
|
|
|
25500
|
subscription
2012
|
265.--
|
300.--
|
|
|
25100
|
TDMA
1/12
|
105.--
|
120.--
|
|
|
25200
|
TDMA
2/12
|
105.--
|
120.--
|
|
|
25300
|
TDMA
3/12
|
105.--
|
120.--
|
|
|
25N50
|
additional samples set
|
65.--
|
75.--
|
|
All quotations indicated are net prices, plus 19% VAT, including postage
and packing
|
